Targeted Therapy
EULAR: Start inflammatory arthritis therapies ‘without delay’ after cancer remission
Targeted therapies for active inflammatory arthritis should be started “without delay” for patients with cancer in remission, according to new EULAR points to consider published in Annals of the Rheumatic Diseases.
Emerging Therapies and Research
Treatment Options and Emerging Therapies
Precision and Immune-Based Therapies
VIDEO: Targeted therapies show ‘dramatic activity’ in cholangiocarcinoma
In this video, Lionel Aurelien Kankeu Fonkoua, MD, discusses the latest developments in targeted therapy options for cholangiocarcinoma.
VIDEO: Strategic sequencing of targeted therapies key in cholangiocarcinoma
In this video, Lionel Aurelien Kankeu Fonkoua, MD, discusses the impact of sequencing targeted therapies when treating patients with cholangiocarcinoma.
VIDEO: Future of bispecifics, CAR-Ts and new therapeutic strategies in multiple myeloma
VIDEO: Patients face many challenges after glomerular disease diagnosis
In these videos, Koyal Jain, MD, MPH, FASN, associate professor of medicine and director, nephrology and hypertension training program at UNC School of Medicin, discusses the latest advancements in glomerular diseases.
Q&A: Asporin linked to ‘more favorable disease profile’ in patients with PAH
Asporin has been discovered as a potential new target that may be used when developing therapeutic interventions for pulmonary arterial hypertension, according to a University of California, Los Angeles (UCLA) press release.
VIDEO: Sequence of treatments for patients with breast cancer ‘continues to evolve’
In this video interview, Sara M. Tolaney, MD, MPH, discusses the individualized sequential therapies provided to patients based on the breast cancer subtype, genomics and other factors.